Viveca Odlind

No ORCID on file · 5 papers in corpus · active 1979-2005

Study types

  • article 5
article 2005
The Impact of Age and Intrauterine Contraception on the Clinical Course of Pelvic Inflammatory Disease
·doi:10.1159/000088751

BACKGROUND: The aim of the study was to investigate the clinical course of pelvic inflammatory disease (PID) and factors that could predict failed conservative treatment of PID. Additionally, the study aimed to examine the role of age and i…

article 2002
Can changes in sex hormone binding globulin predict the risk of venous thromboembolism with combined oral contraceptive pills?
·doi:10.1034/j.1600-0412.2002.810603.x

BACKGROUND: Recent studies have indicated that the risk of thromboembolic disease (VTE) in users of combined oral contraceptive pills (COCs) varies not only with estrogen dose, but also with the progestogen in pills with the same estrogen d…

article 1997
Intrauterine administration of levonorgestrel 5 and 10 μg/24 hours in perimenopausal hormone replacement therapy
·doi:10.3109/00016349709047827

OBJECTIVE: To investigate the clinical effects especially with regard to histopathology and bleeding patterns by levonorgestrel (5- or 10 microg/24 h) released from an intrauterine system (IUS) in combination with estradiol valerate (2 mg) …

article 1997
P-128. Regulation of vascular endothelial growth factor expression in human endometrium by steroids: in-vitro and in-vivo studies
·doi:10.1093/humrep/12.suppl_2.180-b

Abstracts of the 13th Annual Meeting of the ESHRE, Edinburgh 1997 significantly increased (P < 0.05) in Norplant-treated endometrium following RU486 administration.Conclusion: Endometrium exposed to Norplant® and antiprogestogen displayed a…

article 1979
Plasma levels of norethindrone and effect upon ovarian function during treatment with silastic implants containing norethindrone
Contraception ·doi:10.1016/s0010-7824(79)80032-3